Anti-PD-1 therapy combined with chemotherapy in patients with advanced pancreas cancer in a real-world clinical setting.

被引：0
|
作者：
Sun, Danyang
Ma, Junxun
Wang, Jinliang
Han, Chun
Qian, Yuanyu
Chen, Guangying
Li, Xiaoyan
Zhang, Juan
Cui, Pengfei
Du, Wushuang
Wu, Zhaozhen
Chen, Shixue
Zheng, Xuan
Yue, Zhichao
Song, Jia
Cai, Shangli
Hu, Yi
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Dept Med Oncol 1, Beijing, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Dept Med Oncol, Beijing, Peoples R China
[4] Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[5] 3D Med Inc, Dept Med, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e14103
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14103
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Treatment patterns of advanced or recurrent endometrial cancer following platinum-based therapy in the US real-world setting.
    Klink, Andrew J.
    DeMars, Leslie
    Huang, Joice
    Maiese, Eric M.
    Feinberg, Bruce A.
    Hurteau, Jean
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29)
  • [32] Real-world outcomes in patients with locally advanced or metastatic urothelial carcinoma receiving taxane monotherapy following platinum and anti-PD-1/L1 therapy
    Hepp, Zsolt
    Shah, Sonali
    Tan, Katherine
    Balakrishna, Shreya
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [33] Real-world outcomes of combined lenvatinib and anti-PD-1 in advanced melanoma: Lenvamel, a multicenter retrospective study of the French Group of Skin Cancers
    Rousset, Perrine
    Nardin, Charlee
    Maubec, Eve
    Heidelberger, Valentine
    Picard, Alexandra
    Gerard, Emilie
    Kramkimel, Nora
    Steff, Maud
    Quereux, Gaelle
    Gaudy-Marqueste, Caroline
    Lesage, Candice
    Mignard, Claire
    Jeudy, Geraldine
    Jouary, Thomas
    Saint-Jean, Melanie
    Baroudjian, Barouyr
    Archier, Elodie
    Mortier, Laurent
    Lebbe, Celeste
    Montaudie, Henri
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [34] Efficacy and safety of PD-1 inhibitors in combination with chemotherapy versus chemotherapy as first and second line treatment in advanced gastric and gastroesophageal junction cancer: Preliminary data from a real-world setting.
    Hu, Yi
    Li, Tao
    Zhang, Fan
    Zhao, Lei
    Zhao, Xiaochen
    Cai, Shangli
    Zhao, Jing
    Jiao, Shun Chang
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [35] REAL-WORLD TREATMENT PATTERNS AND CLINICAL PREDICTORS OF OVERALL SURVIVAL AMONG ANTI-PD-1 EXPOSED ADVANCED MELANOMA PATIENTS WITH DOCUMENTED EVIDENCE OF DISEASE PROGRESSION
    Pinto, Cathy Anne
    Liu, Xinyue
    Li, Xiaoyun
    Scherrer, Emilie
    Kalabis, Mizuho
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A110 - A111
  • [36] Ixabepilone efficacy and tolerability in metastatic breast cancer (MBC) patients in a real-world setting.
    Hyder, Tara
    Rosenzweig, Margaret Q.
    Brufsky, Adam
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] Treating locally advanced and metastatic cutaneous squamous cell carcinoma with anti-PD-1 drugs: Real-world experience in 72 patients
    Picavia, Robin M.
    Desimone, Jennifer
    Jang, Sekwon
    Stahl, Chelsea
    JAAD INTERNATIONAL, 2024, 14 : 50 - 51
  • [38] Hepatic arterial infusion chemotherapy combined with anti-PD-1/PD-L1 immunotherapy and molecularly targeted agents for advanced hepatocellular carcinoma: a real world study
    Zhang, Weihao
    Zhang, Kai
    Liu, Changfu
    Gao, Wei
    Si, Tongguo
    Zou, Qiang
    Guo, Zhi
    Yang, Xueling
    Li, Mei
    Liu, Dongming
    Mu, Han
    Li, Huikai
    Yu, Haipeng
    Xing, Wenge
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [39] Understanding Real-World Patients' Experience on Pembrolizumab, Anti-Programmed Death 1 Monoclonal Antibody (Anti-PD-1), for Advanced Melanoma: A Qualitative Study
    Wong, Annie
    Billett, Alexandra
    McArthur, Grant
    Milne, Donna
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 148 - 148
  • [40] RETRACTED: Clinical Study of Anti-PD-1 Immunotherapy Combined with Gemcitabine Chemotherapy in Multiline Treatment of Advanced Pancreatic Cancer (Retracted Article)
    Liu, Yanfeng
    Li, Yanchuan
    Du, Shan
    Fan, Li
    Wang, Junyan
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
12345